We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$744B
AUM Growth
+$61.8B
Cap. Flow
-$20.1B
Cap. Flow %
-2.7%
Top 10 Hldgs %
31.13%
Holding
2,974
New
92
Increased
1,834
Reduced
805
Closed
67

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$1.37B
2
INTC icon
Intel
INTC
+$1.28B
3
SCHW
Charles Schwab
SCHW
+$1B
4
NKE icon
Nike
NKE
+$859M
5
UBER icon
Uber
UBER
+$825M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.67B
2
AMZN icon
Amazon
AMZN
+$2.15B
3
NVDA icon
NVIDIA
NVDA
+$1.64B
4
HUM icon
Humana
HUM
+$1.57B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.33B

Sector Composition

Rank Sector Weight
1 Technology 31.09%
2 Healthcare 15.81%
3 Financials 11.13%
4 Consumer Discretionary 10.82%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLX icon
2851
Protalix BioTherapeutics
PLX
$211M
$29K ﹤0.01%
15,982
– –
EOSE icon
2852
Eos Energy Enterprises
EOSE
$1.54B
$28K ﹤0.01%
25,195
+1,305
+5% +$1.9K
INSG icon
2853
Inseego
INSG
$82.6M
$27K ﹤0.01%
12,270
– –
BIRD icon
2854
Smartbird Inc
BIRD
$30.2M
$26K ﹤0.01%
1,030
– –
SKYX icon
2855
SKYX Platforms
SKYX
$163M
$26K ﹤0.01%
15,650
+4,083
+35% +$6.35K
WWR icon
2856
Westwater Resources
WWR
$81M
$26K ﹤0.01%
45,000
– –
BARK icon
2857
BARK
BARK
$96.3M
$25K ﹤0.01%
1,539
– –
ORGN
2858
DELISTED
Origin Materials
ORGN
$24K ﹤0.01%
952
– –
LLAP
2859
DELISTED
Terran Orbital Corporation
LLAP
$24K ﹤0.01%
20,793
+2,563
+14% +$2.14K
ASRT
2860
DELISTED
Assertio
ASRT
$23K ﹤0.01%
1,399
+107
+8% +$2.65K
GWH icon
2861
ESS Tech
GWH
$18.8M
$23K ﹤0.01%
1,343
– –
OPTN
2862
DELISTED
OptiNose
OPTN
$23K ﹤0.01%
1,167
+174
+18% +$3.18K
XFOR icon
2863
X4 Pharmaceuticals
XFOR
$425M
$23K ﹤0.01%
893
– –
FUV
2864
DELISTED
Arcimoto, Inc. Common Stock
FUV
$23K ﹤0.01%
26,725
– –
CTXR icon
2865
Citius Pharmaceuticals
CTXR
$21M
$22K ﹤0.01%
1,125
+125
+13% +$2.37K
WHWK
2866
Whitehawk Therapeutics
WHWK
$269M
$22K ﹤0.01%
10,692
-200,000
-95% -$839K
DNMR
2867
DELISTED
Danimer Scientific, Inc.
DNMR
$22K ﹤0.01%
516
+60
+13% +$3.26K
BW icon
2868
Babcock & Wilcox
BW
$1.46B
$21K ﹤0.01%
13,708
+1,242
+10% +$2.65K
LPTH icon
2869
Lightpath Technologies
LPTH
$862M
$20K ﹤0.01%
15,300
– –
SCWO icon
2870
374Water
SCWO
$41.1M
$20K ﹤0.01%
1,372
+166
+14% +$2.22K
PROK icon
2871
ProKidney
PROK
$304M
$19K ﹤0.01%
+10,485
New +$22.5K
RNAC icon
2872
Cartesian Therapeutics
RNAC
$263M
$19K ﹤0.01%
901
+112
+14% +$3.34K
LICY
2873
DELISTED
Li-Cycle Holdings Corp.
LICY
$19K ﹤0.01%
4,011
+216
+6% +$2.45K
VATE icon
2874
INNOVATE Corp
VATE
$105M
$18K ﹤0.01%
1,414
+361
+34% +$4.42K
KULR icon
2875
KULR Technology Group
KULR
$137M
$17K ﹤0.01%
10,975
– –
113 114
115
116 117

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q4 2023 Portfolio in Review

As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
  • T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
  • T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
  • T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
  • T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
  • T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.

Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.